<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Life Sciences News and Analysis Blog

James Petricek

20+ years operational and management consulting experience in orthobiologics and regenerative medicine with roles in product development, marketing and business development. Prior management positions with BioMimetic Therapeutics and Synthes.

Recent Posts

2 min read

Ending on a Bright Note: Q122 OrthoBio Market Recap

By James Petricek on 7/14/22 9:30 AM

Q122 started slow but ended on a bright note as COVID-19 concerns faded and surgical volumes approached pre-pandemic levels.

Virtually all orthopedic/spine companies experienced the same pattern with elective procedures during the quarter. In general, elective procedure case counts were pressured in January through the beginning of February as a surge in COVID-19 cases impacted patients and contributed to staffing shortages at healthcare facilities. However, by the end of the quarter elective procedures approached or returned to pre-COVID levels.

Among the many topics covered in detail in our comprehensive Q122 OrthoBio Market Recap* are:

Continue Reading
2 min read

COVID-19 Headwinds: Q321 OrthoBio Market Recap

By James Petricek on 12/29/21 11:49 AM

Renewed COVID-19 headwinds mute overall Q3 results, however, the soft tissue repair segment remains resilient

Impact of the Delta variant was felt broadly across OrthoBio, with virtually all publicly traded companies observing a reduction in surgical volume (relative to forecast) directly attributable to a resurgence of COVID-19. Overall, OrthoBio revenue declined, primarily driven by a sharp reduction in Bone Replacement revenue. Several companies noted the decrease in surgical volumes was most acute in August and September due to shortages in hospital staffing. Weakness was most closely tied to deferrable, elective, complex spine procedures.

Among the many topics covered in detail in our comprehensive Q321 OrthoBio Market Recap* are:

Continue Reading

    Follow Us on Social Media

    Recent Articles